Aytu BioScience expands MiOXSYS distribution network in Europe

Aytu BioScience expands MiOXSYS distribution network in Europe

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced an exclusive... Read More

Friday July 14, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS, GryNumber Health

Aytu BioScience appoints Gregory Gould as permanent company CFO

Aytu BioScience appoints Gregory Gould as permanent company CFO

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the hiring of ... Read More

Tuesday June 20, 2017 0 comments Tags: Aytu BioScience, Gregory Gould, Englewood, Josh Disbrow

Ampio appoints Tom Chilcott as interim CEO

Ampio appoints Tom Chilcott as interim CEO

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) today announced it has not renewed the employment agreement of Gregory Gould , Ampio's chief financial officer, which expired on ... Read More

Tuesday June 13, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Gregory Gould, Tom Chilcott, Aytu BioScience

Aytu BioScience acquires Nuelle female sexual health company

Aytu BioScience acquires Nuelle female sexual health company

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced the acquisition of... Read More

Wednesday May 10, 2017 0 comments Tags: Englewood, Aytu BioScience, Nuelle, Fiera, Josh Disbrow

Aytu BioScience sells Primsol to Allegis Holdings

Aytu BioScience sells Primsol to Allegis Holdings

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the divestiture of... Read More

Tuesday April 4, 2017 0 comments Tags: Englewood, Aytu BioScience, Allegis Holdings, Josh Disbrow, Natesto, MiOXSYS

Aytu BioScience expands sales team to support growth of Natesto

Aytu BioScience expands sales team to support growth of Natesto

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the expansion... Read More

Wednesday February 22, 2017 0 comments Tags: Englewood, Aytu BioScience, Natesto, Josh Disbrow

Aytu BioScience launches Asian distribution network for MiOXSYS fertility drug

Aytu BioScience launches Asian distribution network for MiOXSYS fertility drug

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced it entered into... Read More

Friday December 16, 2016 0 comments Tags: Englewood, Aytu BioScience, MiOXSYS, Josh Disbrow

Aytu BioScience announces $8.6M public offering of stock and warrants

Aytu BioScience announces $8.6M public offering of stock and warrants

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced it has priced... Read More

Friday October 28, 2016 0 comments Tags: Englewood, Aytu BioScience